Improved relapse‐free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: Lessons from the randomized European Society for Blood and Marrow Transplantation‐Intergroup study
暂无分享,去创建一个
N. Kröger | D. Niederwieser | P. Dreger | C. Dearden | M. Karas | S. Choquet | M. Leporrier | G. Baerlocher | D. Milligan | J. Dupuis | B. Corront | L. Sutton | J. Schetelig | M. Michallet | J. Homewood | W. Herr | M. Gelder | M. Watson | Theo M. Witte | L. Wreede | M. Os
[1] P. Fayers,et al. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2012, European journal of cancer.
[2] N. Schmitz,et al. Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial. , 2012, Blood.
[3] D. Catovsky,et al. Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial , 2012, Leukemia & lymphoma.
[4] S. Börjeson,et al. A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-up , 2011, Bone Marrow Transplantation.
[5] P. L. Bergsagel,et al. Approach to the treatment of multiple myeloma: a clash of philosophies. , 2011, Blood.
[6] S. Leprêtre,et al. Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC. , 2011, Blood.
[7] R. Brand,et al. Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation. , 2011, Blood.
[8] P. Fayers,et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] M. Watson,et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. , 2004, European journal of cancer.
[10] C Sebban,et al. Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA). , 2000, Blood.
[11] Andrew Bottomley,et al. EORTC QLQ-C30 Scoring Manual , 1995 .
[12] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.